UCSF Receives $824M in NIH Funding, Driving Medical Breakthroughs

The grants enable UCSF researchers to develop better therapies for cancer, diabetes, and dementia, pursue new technologies with AI, and fight infectious diseases.

Published on Mar. 11, 2026

Got story updates? Submit your updates here. ›

The University of California, San Francisco (UCSF) received $824 million from the National Institutes of Health (NIH) in 2025 to drive groundbreaking research in medicine and science. The funding enables UCSF researchers to develop new treatments for diseases like cancer, diabetes, and dementia, as well as pursue innovative technologies using AI to combat infectious diseases like tuberculosis, HIV, and malaria.

Why it matters

Federal funding is crucial for advancing medical research and expanding our understanding of human biology. The NIH grants not only support UCSF's pioneering work, but also drive economic growth in the San Francisco Bay Area's robust life sciences sector, which employs over 150,000 people and generates $123.6 billion for the local economy.

The details

UCSF was the largest public recipient of NIH awards in 2025, with its Schools of Medicine, Pharmacy, Dentistry, and Nursing receiving a combined $811.9 million. This funding enables projects like developing computer tools to better diagnose neurological diseases, designing new proteins to improve cell therapies, and building smarter hospital monitoring systems using AI.

  • The NIH grants were awarded in the fiscal year starting October 1, 2024 and ending September 30, 2025.
  • UCSF has been a leading recipient of NIH funding for many years, reflecting its status as a premier research institution.

The players

UCSF

The University of California, San Francisco is a top public research university focused on health sciences, with schools of medicine, pharmacy, dentistry, and nursing.

National Institutes of Health (NIH)

The NIH is the primary agency of the United States government responsible for biomedical and public health research, founded in 1887.

Sam Hawgood, MBBS

The chancellor of the University of California, San Francisco, who praised the importance of federal research funding.

Got photos? Submit your photos here. ›

What they’re saying

“Federal funding is indispensable to advancing medicine. It enables the basic science that expands our understanding of human biology and creates the foundation for new strategies to prevent and treat disease.”

— Sam Hawgood, Chancellor, University of California, San Francisco (Mirage News)

What’s next

UCSF researchers will continue to utilize the NIH funding to drive groundbreaking discoveries and innovations in medicine and healthcare, with the goal of developing new treatments and technologies that improve patient outcomes and advance the field of biomedical research.

The takeaway

The significant NIH funding awarded to UCSF underscores the vital role that federal investment plays in supporting cutting-edge medical research, fueling scientific breakthroughs, and strengthening the United States' leadership in healthcare and the life sciences industry.